|
|
|
Axxess Pharma, Inc. (OTCPK: AXXE) is a Bio Stock that could soon take steroids!
|
|
| Hello traders, it has been a slow summer, but we're proud to bring you the next play that we feel could bring our subscribers an opportunity to profit big time! |
|
|
|
|
|
|
|
|
|
| This seems to have gone relatively un-noticed, but AXXE has been on top of its filings. Their losses decreased dramatically this last quarter, which is good for the fundamental side of things. They also took the step to become OTC Pinksheets Current last month. You have to wonder why a company would take this step to reveal more information to shareholders. Do they expect for their books to look better soon? |
|
| According to the company's website, they have THREE products launching in the Summer of 2013!
This could be the ground floor opportunity before things get really heated when others find out about the opportunity here!
|
|
|
|
|
|
|
"We are pleased to have accomplished this task for our shareholders. We remain focused on complete transparency and generating revenues by the second half of 2013. As the weeks and months progress, we will continue to release news regarding product licensing, product distribution, revenues, and brand marketing." Dr. Bagi further stated, "During the last 15 months, the company has worked diligently to bolster management, and initiate revenues and profits through our prescription drugs and over-the-counter nutritional supplements."
It seems that the company has been wasting no time, and that things are really close to kicking off, as it is now the second half of 2013.
|
|
|
|
|
|
|
Keep your eyes on AXXE! Our coverage isn't done, so stay tuned!
|
|
|
|
|
|
|
|
Crux Media Group, LLC. has been compensated 350 by a non-controlling third party for two days of social media, email alerts, and profiling of AXXE.
|
|
|
